Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

i.v. iron sucrose

Phase 2Small molecule

JJ. Uriach and Company

1

Indications

2

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

Iron Deficiency Anemia (IDA)Active, not recruiting

Iron Deficiency Anemia (IDA)Phase 2

Active, not recruiting

Timeline

Expected Milestones

Q1 2027

Phase 2Active, not recruiting

Iron Deficiency Anemia (IDA)

NCT07706582

Clinical

Trials by Indication[1]

Iron deficiency anemia1 trial

Iron Therapy in Colo-Rectal Neoplasm and Iron Deficiency Anemia: Intravenous Iron Sucrose Versus Oral Ferrous Sulphate.

Unknown status·JJ. Uriach and Company·Phase 4·NCT00199277·150 enrolled

Iron Deficiency Anemia (IDA)1 trial

Evaluating the Therapeutic Impact of Lactoferrin on Complications in Patients With End-Stage Renal Disease

Active, not recruiting·BBeni-Suef University·Phase 2·NCT07706582·108 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for i.v. iron sucrose. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — i.v. iron sucrose compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for i.v. iron sucrose. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — J. Uriach and Company company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: JJ. Uriach and Company

Related News